Brilinta and Breastfeeding
It is unknown if Brilinta (ticagrelor) passes through breast milk. Since no studies have been performed on breastfeeding and Brilinta, it is also unclear whether the medicine would cause problems in a nursing infant. Your healthcare provider may recommend that you stop breastfeeding while taking this drug, since it is taken with aspirin -- a drug that should generally be avoided by nursing women.
Currently, it is unknown if Brilinta™ (ticagrelor) is safe for use during breastfeeding. Therefore, be sure to talk with your healthcare provider before nursing a child while taking this medication.
No studies have checked to see if Brilinta passes through breast milk in humans, although the drug is known to pass through breast milk in rats. It is entirely unknown if this medication could cause problems for breastfed infants.
It should be noted that Brilinta is always used together with aspirin, and aspirin should generally be avoided by women who are breastfeeding. If your healthcare provider recommends Brilinta for you, it may be best to stop breastfeeding, since this drug can be a life-saving medication and is generally only used in serious situations, such as after a heart attack.
The benefits of Brilinta for you probably outweigh the benefits of breastfeeding for both you and your child.
You should discuss breastfeeding and Brilinta with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.